1986
W. Zhou et al. / Tetrahedron 65 (2009) 1982–1987
(neat): 3197, 3089, 2966, 2903, 1687, 1610, 1590, 1489, 1398, 1373,
1196, 1088, 816 cmꢃ1; MS (70 eV): m/z (%) 181.1 (Mþ, 35Cl, 100),
183.2 (Mþ, 37Cl, 30); C9H8ClNO: calcd C 59.52, H 4.44, N 7.71; found
C 59.50, H 4.69, N 7.54.
7.20–7.13 (m, 2H), 6.98 (t, J¼7.2 Hz, H), 6.84 (d, J¼7.8 Hz, 1H), 3.00
(dd, J¼14.1, 4.5 Hz, 1H), 2.79–2.62 (m, 2H), 1.29 (d, J¼6.6 Hz, 3H);
13C NMR (75 MHz, CDCl3)
d 174.8, 137.2, 128.0, 127.4, 123.5, 122.8,
115.2, 34.9, 33.3, 15.3; IR (neat): 3199, 3071, 2987, 2926, 1667, 1593,
1491, 1391, 1285, 761 cmꢃ1; MS (70 eV): m/z (%) 161.2 (Mþ, 100);
C10H11NO: calcd C 74.51, H 6.88, N 8.69; found C 74.33, H 6.86,
N 8.65.
4.9. 3,4-Dihydro-(1H)-1,7-naphthyridin-2-one (3h)
The reaction of 3-amino-4-iodopyridine (110 mg, 0.5 mmol), 6a
(217 mL, 2 mmol), n-Bu3SnH (201 mL, 0.75 mmol), and AIBN (33 mg,
4.14. 3-Benzyl-3,4-dihydro-(1H)-quinolin-2-one (3m)
0.2 mmol) in DMSO (2 mL) was heated for 24 h to afford 17 mg
(23%) of 3h as solid; mp (ethyl acetate): 194–196 ꢀC; 1H NMR
The reaction of 2-iodoaniline (109 mg, 0.5 mmol), 6f (380 mg,
(300 MHz, CDCl3)
1H), 7.12 (d, J¼4.6 Hz, 1H), 3.01 (t, J¼7.6 Hz, 2H), 2.69 (t, J¼7.6 Hz,
2H); 13C NMR (75 MHz, CDCl3)
171.5, 144.5, 136.7, 134.6, 132.0,
d
9.48 (br s, 1H), 8.26 (d, J¼4.6 Hz, 1H), 8.23 (s,
2 mmol), n-Bu3SnH (201 mL, 0.75 mmol), and AIBN (33 mg,
0.2 mmol) in DMSO (2 mL) was heated for 17 h to afford 52 mg
(44%) of 3m as solid; mp (ethanol): 114–116 ꢀC; 1H NMR (300 MHz,
d
122.5, 29.8, 24.7; IR (neat): 3190, 3091, 2963, 2885, 1700, 1645, 1611,
1580, 1491, 1404, 1381, 1338, 1272, 1199, 912, 827 cmꢃ1; MS (70 eV):
m/z (%) 148.3 (Mþ, 100); C8H8N2O: calcd C64.85, H 5.44, N 18.91;
found C 64.74, H 5.31, N 18.70.
CDCl3)
d
8.86–8.76 (br d, 1H), 7.35–7.16 (m, 6H), 7.80 (d, J¼7.2 Hz,
1H), 6.98 (t, J¼7.4 Hz, 1H), 6.84 (d, J¼7.8 Hz, 1H), 3.34 (dd, J¼13.6,
3.7 Hz, 1H), 2.89–2.78 (m, 2H), 2.70–2.58 (m, 2H); 13C NMR
(75 MHz, CDCl3)
d 173.4, 138.9, 136.9, 129.2, 128.5, 128.4, 127.5,
126.4, 123.1,123.0,115.1, 41.8, 35.3, 29.4; IR (neat): 3210, 3106, 3063,
3025, 2997, 2941, 1676, 1596, 1494, 1391, 1294, 752, 697 cmꢃ1; MS
(70 eV): m/z (%) 237.3 (Mþ, 53), 146.2 (100); C16H15NO: calcd C
80.98, H 6.37, N 5.90; found C 80.80, H 6.15, N 5.96.
4.10. N-Methyl-3,4-dihydroquinolin-2-one (3i16
)
The reaction mixture of 2-iodo-N-methylaniline (117 mg,
0.5 mmol), 6a (217 L, 2 mmol), n-Bu3SnH (201 L, 0.75 mmol), and
AIBN (33 mg, 0.2 mmol) in DMSO (2 mL) was heated for 36 h to
afford 36 mg (45%) of 3i as liquid; 1H NMR (300 MHz, CDCl3)
7.29–
m
m
4.15. 3-Phenyl-3,4-dihydro-(1H)-quinolin-2-one (3n)
d
7.82 (m, 1H), 7.17 (d, J¼7.5 Hz, 1H), 7.05–6.96 (m, 2H), 3.36 (s, 3H),
The reaction of 2-iodoaniline (109 mg, 0.5 mmol), 6g (352 mg,
2.91 (t, J¼7.3 Hz, 2H), 2.65 (t, J¼7.3 Hz, 2H); 13C NMR (75 MHz,
2 mmol), n-Bu3SnH (201
0.2 mmol) in DMSO (2 mL) for 17 h afforded 29 mg (26%) of 3n as
solid; mp (ethanol): 174–176 ꢀC; 1H NMR (300 MHz, CDCl3)
9.08
mL, 0.75 mmol), and AIBN (33 mg,
CDCl3) d 170.5, 140.6, 127.7, 127.4, 126.2, 122.7, 114.6, 31.7, 29.5, 25.4;
IR (neat): 2923, 1676, 1602, 1472, 1367, 1131, 756 cmꢃ1; MS (70 eV):
d
m/z (%) 161.3 (Mþ, 57), 118.2 (100).
(br s, 1H), 7.32–7.14 (m, 7H), 6.99 (t, J¼7.4 Hz, 1H), 6.81 (d, J¼7.8 Hz,
1H), 3.88 (t, J¼7.8 Hz, 1H), 3.30–3.00 (m, 2H); 13C NMR (75 MHz,
4.11. 3,4-Dihydro-6-amino-7-iodo-(1H)-quinolin-2-one (3j)
CDCl3)
d 172.3, 138.4, 137.0, 128.7, 128.1, 128.0, 127.6, 127.3, 123.2,
115.4, 46.5, 33.5; IR (neat) 3218, 3065, 3029, 2944, 1680, 1597, 1492,
1379, 1268, 751 cmꢃ1; MS (70 eV): m/z (%) 223.4 (Mþ, 100);
C15H13NO: calcd C 80.69, H 5.87, N 6.27; found C 80.40, H 5.71,
N 6.15.
The reaction of 2,5-diiodobenzene-1,4-diamine (180 mg,
0.5 mmol), 6a (434 mL, 4 mmol), n-Bu3SnH (404 mL, 1.5 mmol), and
AIBN (66 mg, 0.4 mmol) in DMSO (2 mL) afforded 52 mg (36%) of 3j
as solid; mp (ethanol): 196–198 ꢀC; 1H NMR (300 MHz, DMSO-d6)
d
9.74 (br s, 1H), 7.04 (s, 1H), 6.58 (s, 1H), 4.84 (br s, 2H), 2.69 (t,
Acknowledgements
J¼7.4 Hz, 2H), 2.33 (t, J¼7.4 Hz, 2H); 13C NMR (75 MHz, DMSO-d6)
d
169.4, 143.5, 129.9, 125.4, 124.0, 113.6, 80.2, 30.4, 24.9; IR (neat):
Financial support from Peking University and National Science
Foundation of China (Nos. 20702002 and 20872003) and the Ph.D.
Programs Foundation of Ministry of Education of China (No.
20070001808) are greatly appreciated.
3405, 3321, 3179, 3036, 2939, 1655, 1497, 1399, 1261, 1195, 872,
678 cmꢃ1; MS (70 eV): m/z (%) 288.1 (Mþ, 100); C9H9IN2O: calcd C
37.52, H 3.15, N 9.72; found C 37.62, H 3.29, N 9.61.
4.12. Benzyl (2-oxo-3,4-dihydro-(1H)-quinolin-3-yl)
acetate (3k)
Supplementary data
Experimental details and NMR spectra are available as Supple-
mentary data. Supplementary data associated with this article can
The reaction of 2-iodoaniline (109 mg, 0.5 mmol), 6d (620 mg,
2 mmol), n-Bu3SnH (201
0.2 mmol) in DMSO (2 mL) afforded 79 mg (54%) of 3k as solid; mp
(ethanol): 146–148 ꢀC; 1H NMR (300 MHz, CDCl3)
9.15 (br s, 1H),
mL, 0.75 mmol), and AIBN (33 mg,
d
References and notes
7.40–7.20 (m, 5H), 7.20–7.09 (m, 2H), 6.98 (d, J¼7.5 Hz, 1H), 6.80 (d,
J¼7.8 Hz, 1H), 5.23–5.12 (m, 2H), 3.16–2.78 (m, 4H), 2.54(dd, J¼18,
1. For leading reviews, see: (a) Parsons, P. J.; Penkett, C. S.; Shell, A. J. Chem. Rev.
1996, 96, 195–206; (b) Tietze, L. F.; Modi, A. Med. Res. Rev. 2000, 20, 304–322;
(c) Mueller, T. J. J.; D’Souza, D. M. Pure Appl. Chem. 2008, 80, 609–620.
2. (a) Takai, K.; Matsukawa, N.; Takahashi, A.; Fujii, T. Angew. Chem., Int. Ed. 1998,
37, 152–155; (b) Bazin, S.; Feray, L.; Siri, D.; Naubron, J.-V.; Bertrand, M. P. Chem.
Commun. 2002, 2506–2507; (c) Ueda, M.; Miyabe, H.; Sugino, H.; Miyata, O.;
Naito, T. Angew. Chem., Int. Ed. 2005, 44, 6190–6193; (d) Godineau, E.; Landais, Y.
J. Am. Chem. Soc. 2007, 129, 12662–12663.
3. (a) Hayashi, H.; Miwa, Y.; Miki, I.; Ichikawa, S.; Yoda, N.; Ishii, A.; Kono, M.; Su-
zuki, F. J. Med. Chem.1992, 35, 4893–4902; (b) Carling, R. W.; Leeson, P. D.; Moore,
K. W.; Smith, J. D.; Moyes, C. R.; Mawer, I. M.; Thomas, S.; Chan, T.; Baker, R.;
Foster, A. C.; Grimwood, S.; Kemp, J. A.; Marshall, G. R.; Tricklebank, M. D.;
Saywell, K. L. J. Med. Chem. 1993, 36, 3397–3408; (c) Jones, G. In Comprehensive
Heterocyclic Chemistry II; Katritzky, A. R., Rees, C. W., Scriven, E. F., Eds.; Perga-
mon: Oxford, UK,1996; pp 167; (d) Patel, M.; McHugh, R. J.; Cordova, B. C.; Klabe,
R. M.; Bacheler, L. T.; Erickson-Viitanen, S.; Rodgers, J. D. Bioorg. Med. Chem. Lett.
2001,11 1943–1945; (e) Uchida, R.; Imasato, R.; Shiomi, K.; Tomoda, H.; Omura, S.
Org. Lett. 2005, 7, 5701–5704; (f) Turner, K. L.; Baker, T. M.; Islam, S.; Procter, D. J.;
9 Hz, 1H); 13C NMR (75 MHz, CDCl3)
d 172.5, 171.8, 137.0, 135.8,
128.5, 128.1, 127.9, 127.6, 123.1, 123.0, 115.3, 66.5, 36.7, 34.4, 31.0; IR
(neat): 3198, 3063, 2923, 1726, 1669, 1595, 1492, 1383, 1351, 1278,
1187, 1174, 1158, 742 cmꢃ1; MS (70 eV): m/z (%) 295.3 (Mþ, 2), 146.3
(100); C18H17NO3: calcd C 73.20, H 5.80, N 4.74; found C 73.31, H
5.76, N 4.66.
4.13. 3,4-Dihydro-3-methyl-(1H)-quinolin-2-one (3l)
The reaction of 2-iodoaniline (109 mg, 0.5 mmol), 6e (214
2 mmol), n-Bu3SnH (201 L, 0.75 mmol), and AIBN (33 mg,
0.2 mmol) in DMSO (2 mL) afforded 60 mg (75%) of 3l as solid; mp
(ethanol): 134–136 ꢀC; 1H NMR (300 MHz, CDCl3)
9.03 (br s, 1H),
mL,
m
d